Canaccord Genuity reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); Hercules Loan Shores Up Cash for ARX-01 Pivotal Trial Costs

Go back to Canaccord Genuity reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); Hercules Loan Shores Up Cash for ARX-01 Pivotal Trial Costs
ACELRX PHARMA (NASDAQ: ACRX) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $5.88 
Open $0.25    52 Week Low $2.40 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $-1.50 
Volume